Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-104325)

Filing Details

Accession Number:: 0001209191-16-104325
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-02 14:58:28
Reporting Period:: 2016-03-01

Filing Date:: 2016-03-02
Accepted Time:: 2016-03-02 14:58:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1198230	J Martha Demski	C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-01	10,000	$4.89	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,788	Indirect	By the Martha J. Demski Trust u/a 10/01/94

Footnotes

The range of purchase prices paid is $4.89 to $4.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.